Döhler agrees £183m takeover of Treatt (LON: TET) at 305p as Natara’s lapsed offer reshapes the flavour ingredients map

Treatt PLC (LON: TET), the Bury St. Edmunds-based flavour and fragrance ingredients group, has agreed terms on a £183 million recommended cash offer from Döhler Finance Management B.V., an indirect wholly-owned subsidiary of Germany’s Döhler Group SE. Under the terms announced on 29 April 2026, Döhler will pay 305 pence in cash for each Treatt Share, with shareholders also entitled to retain the previously announced final dividend of 3 pence per Treatt Share for the year ended 30 September 2025, payable on 13 May 2026. The headline price represents a 48 per cent premium to the 28 April 2026 closing price of 206 pence per Treatt Share, and a 5 per cent uplift to the lapsed 290 pence “final” cash offer made by rival bidder Natara Global Limited in October 2025. Treatt Shares had been trading near the bottom of a 12-month range of 180p to 413.50p before the announcement, and the offer effectively ends a six-month vacuum in the takeover process for one of the United Kingdom’s better-known mid-cap natural ingredients businesses.

How does Döhler’s 305 pence cash offer for Treatt PLC compare with Natara’s lapsed bid and the company’s depressed share price?

The pricing of the Döhler offer is unusual in mid-cap UK takeover history because it was set against a competing bid that had already been recommended, increased, and then allowed to lapse. Natara’s original 260 pence cash offer dated 8 September 2025 was followed by an increased 290 pence “final” offer on 6 October 2025, both of which the Treatt Board recommended at the time. The new Döhler offer of 305 pence sits 17 per cent above Natara’s original number and only 5 per cent above Natara’s increased final price, which means the absolute uplift over the highest competing bid is modest in cash terms but materially higher than where the shares actually traded on the open market through the spring of 2026.

The 48 per cent premium to the 206 pence closing price on 28 April 2026 is therefore doing two jobs at once. It compensates Treatt Shareholders for the time-value erosion of holding shares through a failed auction, and it provides a defensible exit floor at a moment when the consensus analyst target price of around 287 pence sat materially below historical highs. Treatt’s market capitalisation before the announcement stood at around £125 million on 59.04 million shares in issue, against a 52-week high of 413.50 pence reached when Natara’s process was live and competitive tension was assumed to support the equity. The drift back to 206 pence reflects what happens when a recommended auction collapses and the controlling stake builder, Döhler, is the only credible buyer left at the table.

For long-term holders, the Döhler offer locks in a number that is well below the 12-month high but well above the post-collapse trading floor of 180 pence. That asymmetry is the single most important framing investors will apply when the Scheme Document arrives.

Why does Döhler already control 27.9 per cent of Treatt PLC and what does that tell shareholders about leverage in the deal?

Döhler is not arriving at this transaction as an outside bidder. During the Natara Offer period, Döhler accumulated interests in Treatt Shares that, as at 28 April 2026, carried in aggregate approximately 27.9 per cent of the voting rights in Treatt. On 30 September 2025, Döhler had publicly stated under Rule 2.8 of the City Code that it was not considering making an offer for Treatt, a position that restricted further bid activity for a defined period. On 19 January 2026, Treatt and Döhler entered into a Relationship Agreement that gave Döhler the right to nominate one director, and Helga Moelschl was appointed to the Treatt Board on 1 February 2026 pursuant to that right.

The combination of a sub-30 per cent voting block, a board seat, and historical commercial ties as both supplier and customer to Treatt placed Döhler in a structurally privileged position. That position becomes especially significant when read alongside the acceptance condition disclosed in the announcement, which can be reduced from the standard 90 per cent threshold subject to Panel consent and the terms of the offer. With 27.9 per cent already locked in, plus letters of intent from Treatt Shareholders representing approximately 12.0 per cent of issued share capital and irrevocable undertakings from Treatt Directors covering a further 0.04 per cent, Döhler is effectively starting the formal acceptance process with around 40 per cent of the register pre-aligned.

For independent shareholders, this matters in two ways. It substantially reduces deal completion risk, which is part of why the Independent Committee, formed of all Treatt Board members other than Helga Moelschl, has chosen to recommend the offer. It also means that any third party considering a counter-bid would need to convince Döhler to sell a near-28 per cent block at a higher price, an unlikely scenario given Döhler’s strategic intent. The deal economics therefore reflect a controlled rather than a contested process, and the 305 pence price should be read in that context.

What is the strategic rationale behind Döhler Group SE acquiring Treatt PLC and how does it reshape the natural ingredients value chain?

Döhler Group SE, founded in 1838 and described in the announcement as a family-owned business with a 185-year heritage and a multinational footprint in natural ingredients, ingredient systems, and integrated solutions for the food, beverage, and lifestyle industries, has framed the Treatt acquisition as a complementary rather than overlapping combination. Treatt’s specialism in citrus, tea, coffee, fruit, herbs, spices, and high-impact aroma chemicals sits adjacent to Döhler’s broader technology-driven ingredient systems and finished application capabilities. The strategic case rests on three pillars set out in the announcement: complementary portfolios and geographic reach, a stronger customer proposition supported by a strong United States footprint, and the ability of Treatt to benefit from Döhler Group’s scale, capital, and capacity to invest in long-term growth.

The United States dimension is the most commercially significant. Treatt generates a majority of its revenue from its United States business, and Döhler’s announcement explicitly references the strengthened U.S. food and beverage proposition that the combined platform would offer. The flavour and fragrance ingredients market has been consolidating for several years around scale players such as Givaudan, IFF, Symrise, and Firmenich, and a combined Döhler-Treatt entity would not match those incumbents in scale but would have a sharper focus on natural extracts and integrated solutions for beverage and consumer product clients. That positioning is differentiated rather than direct competition, which is part of why competitive concerns at the regulatory level appear manageable on the face of the announcement.

The longer-term industrial logic is that natural ingredients businesses with mid-cap public market valuations have struggled to fund the capital cycles needed to scale customer servicing in the United States, particularly in a period of input cost volatility and capacity tightness. Döhler’s private ownership structure and balance sheet allow Treatt to invest behind the strategy already outlined by Treatt management without quarterly public market scrutiny. For Döhler, absorbing Treatt removes a respected but sub-scale competitor from the public market and folds its citrus and tea capabilities into a much larger ingredient systems business that can cross-sell into existing Döhler customers globally.

What execution risks does the Döhler-Treatt acquisition face on regulatory clearance, conditions, and timing?

The Acquisition is being implemented by way of a Court-sanctioned scheme of arrangement under Part 26 of the Companies Act, although Döhler reserves the right to switch to a Takeover Offer subject to Panel consent. The Scheme Document is expected to be posted to Treatt Shareholders within 28 days of the announcement, and the Acquisition is subject to conditions to be set out in full in that document, including standard regulatory approvals.

Three execution risks merit specific attention. First, antitrust review in jurisdictions where Döhler and Treatt have material overlapping customer relationships could extend the timetable, although the adjacency framing in the announcement suggests the parties view substantive overlap as limited. Second, the Long Stop Date provisions create a hard timing boundary, and any extension would require agreement between Döhler and Treatt. Third, the right reserved by Döhler to reduce the consideration if Treatt declares any further dividend or distribution before the Effective Date, other than the protected 3 pence final dividend, creates a constraint on Treatt’s capital return policy through completion.

For Treatt’s existing minority shareholders, the more practical risk concerns the acceptance condition. The announcement allows Döhler to seek Panel consent to reduce the threshold from 90 per cent to a lower level, potentially as low as just over 50 per cent of the voting rights. This matters because shareholders who do not accept the offer could find themselves holding minority positions in a delisted, Döhler-controlled Treatt where liquidity, governance, and dividend policy would all change materially. The structural pressure to accept therefore goes beyond the headline premium.

What does the Treatt takeover by Döhler signal about consolidation pressure across the United Kingdom mid-cap flavour and fragrance sector?

The Treatt situation illustrates a broader pattern that has been visible across United Kingdom mid-cap specialty ingredients and consumer-facing manufacturers over the last 18 months. Public market valuations for sub-£500 million businesses with strong technical positioning but limited scale advantages have compressed materially relative to private market clearing prices, and that gap creates a recurring opportunity for trade buyers and private capital to take such businesses out of public ownership.

Treatt’s specific journey, with a recommended Natara offer at 290 pence collapsing and Döhler then closing at 305 pence after months of stake-building, also reflects the difficulty boards face in running competitive auctions when one industrial bidder has the patience, capital base, and pre-existing commercial relationship to wait out the process. The Independent Committee has acknowledged in the announcement that the level of the Döhler offer, in conjunction with the deal structure and limited realistic alternatives once Natara had walked away, was the most attractive outcome reasonably available. That candour is unusual and points to a wider truth about boards in this situation. When a strategic shareholder holds close to 28 per cent and has the capacity to be either a constructive partner or a passive blocker of any rival deal, the practical bid universe for the remaining shareholders narrows quickly.

For peer companies still listed in the natural ingredients and specialty flavour space, the Treatt outcome raises a strategic question about whether public market discipline is actually rewarding the technical investment cycle their businesses require. Several similar situations are likely to surface over the next 12 to 18 months, particularly where European trade buyers with private ownership structures see opportunities to consolidate United States customer access through London-listed assets trading well below book or replacement value.

Key takeaways on what the Döhler acquisition of Treatt PLC means for shareholders, competitors, and the wider ingredients industry

• Döhler’s 305 pence cash offer values Treatt PLC at approximately £183 million on a fully diluted basis, with the 3 pence final dividend preserved on top, delivering a 48 per cent premium to the 206 pence pre-announcement close.
• The 5 per cent uplift over Natara’s lapsed 290 pence final offer is modest in cash terms but reflects Döhler’s near-monopoly position as the only credible bidder once Natara withdrew and Döhler had built a 27.9 per cent voting stake.
• Pre-aligned support of approximately 40 per cent of the share register, combining Döhler’s 27.9 per cent stake, 12.0 per cent letters of intent, and 0.04 per cent director undertakings, materially reduces completion risk on the scheme.
• The Treatt Independent Committee’s recommendation, given Helga Moelschl’s recusal as Döhler’s nominee director, signals that the board judged the offer the best practical outcome available rather than the highest theoretical valuation.
• Strategic logic centres on combining Treatt’s natural extract capabilities in citrus, tea, coffee, and fruit with Döhler’s technology-driven ingredient systems, with the United States customer footprint the most commercially material element.
• For Givaudan, IFF, Symrise, and Firmenich, a Döhler-Treatt combination is not a scale threat but does remove a respected mid-cap natural ingredients pure play from the competitive landscape and consolidates a credible alternative for beverage majors.
• Antitrust review across multiple jurisdictions remains the principal execution variable, although the adjacency framing in the announcement suggests the parties view material overlap as limited.
• Minority shareholders face structural pressure to accept once any reduced acceptance condition is met, given Döhler’s likely intent to delist and absorb Treatt into its private ownership structure.
• The transaction confirms that mid-cap United Kingdom specialty ingredients businesses with strong technical positioning but limited scale remain vulnerable to take-private bids from European trade buyers willing to invest through public market cycles.
• For the broader London market, the Treatt outcome is another data point in the persistent valuation gap between public mid-caps and private market clearing prices, and points to further consolidation pressure across the natural ingredients and flavour value chain over the next 12 to 18 months.